SouthState Corp Increases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SouthState Corp raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 39,315 shares of the medical equipment provider’s stock after purchasing an additional 2,035 shares during the period. Intuitive Surgical accounts for 1.3% of SouthState Corp’s investment portfolio, making the stock its 21st largest holding. SouthState Corp’s holdings in Intuitive Surgical were worth $20,521,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of ISRG. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $25,000. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $31,000. Finally, MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. UBS Group raised their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Raymond James raised their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Finally, Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock worth $17,691,621 over the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 1.6 %

NASDAQ:ISRG opened at $484.44 on Monday. The firm has a 50-day moving average price of $567.46 and a two-hundred day moving average price of $531.94. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The company has a market capitalization of $172.55 billion, a P/E ratio of 75.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.